Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on November 4, 2025
November 4, 2025
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
November 4, 2025
Anaptys Announces Participation in November Investor Conferences
Indeterminate
GlobeNewswire
November 4, 2025
Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
November 4, 2025
CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025
Indeterminate
GlobeNewswire
November 4, 2025
Spyre Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Indeterminate
GlobeNewswire
November 4, 2025
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
Indeterminate
GlobeNewswire
November 4, 2025
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 4, 2025
Revolution Medicines to Participate in November 2025 Investor Conferences
Indeterminate
GlobeNewswire
November 4, 2025
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
November 4, 2025
Prenetics Announces Third Quarter 2025 Financial Results Release Date and Inaugural Earnings Conference Call
Indeterminate
GlobeNewswire
November 4, 2025
Sight Sciences to Present at Two Upcoming Investor Conferences
Indeterminate
GlobeNewswire
November 4, 2025
Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
Indeterminate
GlobeNewswire
November 4, 2025
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
Indeterminate
GlobeNewswire
November 4, 2025
Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements
Indeterminate
GlobeNewswire
November 4, 2025
Standard BioTools Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 4, 2025
Ceribell Reports Third Quarter 2025 Financial Results
Indeterminate
GlobeNewswire
November 4, 2025
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Indeterminate
GlobeNewswire
November 4, 2025
ImmuCell Announces Onboarding of New CEO and Related Management Changes
Indeterminate
GlobeNewswire
November 4, 2025
OnKure Therapeutics to Participate in Upcoming Investor Conferences
Indeterminate
GlobeNewswire